The authors showed that p38MAPKa inhibition limited tumor growth by reprograming the metastatic tumor microenvironment in a CD4+ T cell, IFNy, and macrophage dependent manner.
[Cancer Discovery]
Home Newsletters Human Immunology News p38MAPKa Stromal Reprogramming Sensitizes Metastatic Breast Cancer to Immunotherapy
